Predictive Value of Circulating Melanoma Cells (CMCs) in Metastatic Melanoma (MM) Patients Treated With Selective Inhibitors of BRAF
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Proto oncogene protein b raf inhibitors (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics
- Acronyms CMCBRAF
- 03 Oct 2016 Biomarkers information updated
- 23 Jul 2013 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
- 03 Jul 2013 New trial record